Common Cold News and Research

RSS
Analysis of the immune landscape in mild-to-moderate COVID-19

Analysis of the immune landscape in mild-to-moderate COVID-19

Low dose of Moderna COVID-19 vaccine generates durable immune response

Low dose of Moderna COVID-19 vaccine generates durable immune response

Gorillas at Atlanta Zoo have been infected by SARS-CoV-2

Gorillas at Atlanta Zoo have been infected by SARS-CoV-2

As COVID restrictions were removed, Texas saw an increase in seasonal respiratory virus infections

As COVID restrictions were removed, Texas saw an increase in seasonal respiratory virus infections

No evidence of pre-existing antibody and B cell immunity against SARS-CoV-2 in unexposed adults

No evidence of pre-existing antibody and B cell immunity against SARS-CoV-2 in unexposed adults

Research reveals a new role for platelets in COVID-19 blood vessel damage

Research reveals a new role for platelets in COVID-19 blood vessel damage

Using infodemiology to understand symptoms of SARS-CoV-2 Lambda variant

Using infodemiology to understand symptoms of SARS-CoV-2 Lambda variant

Investigational vaccine does not provide sufficient protection against HIV infection

Investigational vaccine does not provide sufficient protection against HIV infection

COVID-19 pandemic illuminates the importance of airborne transmission of respiratory viruses

COVID-19 pandemic illuminates the importance of airborne transmission of respiratory viruses

Improved understanding of aerosol transmission could help control airborne respiratory viruses

Improved understanding of aerosol transmission could help control airborne respiratory viruses

White-tailed deer are highly susceptible to SARS-CoV-2 infection

White-tailed deer are highly susceptible to SARS-CoV-2 infection

COVID-19 risks likely to shift from older adults to younger children

COVID-19 risks likely to shift from older adults to younger children

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Study: IgG antibodies against SARS-CoV-2 remain stable, or even increase, seven months after infection

Study: IgG antibodies against SARS-CoV-2 remain stable, or even increase, seven months after infection

One billion doses of Oxford-AstraZeneca COVID-19 vaccine released

One billion doses of Oxford-AstraZeneca COVID-19 vaccine released

Existing drug may be effective in treating SARS-CoV-2

Existing drug may be effective in treating SARS-CoV-2

Study looks at potent phytocompounds from Himalayan herbs to treat COVID-19

Study looks at potent phytocompounds from Himalayan herbs to treat COVID-19

Children exposed to second-hand marijuana smoke may experience viral respiratory infections

Children exposed to second-hand marijuana smoke may experience viral respiratory infections

Novel atlas charts how different antibodies attack a major piece of SARS-CoV-2 machinery

Novel atlas charts how different antibodies attack a major piece of SARS-CoV-2 machinery

Can prior human seasonal coronavirus antibody response patterns predict SARS-CoV-2 inhibition?

Can prior human seasonal coronavirus antibody response patterns predict SARS-CoV-2 inhibition?